Font Size: a A A

The Clinical Observation Of Ulcerative Colitis (Active Stage)Treating By Kui-xun Kang Joint Chang Mei (Olsalazine)

Posted on:2013-04-24Degree:MasterType:Thesis
Country:ChinaCandidate:J H ChenFull Text:PDF
GTID:2234330374493942Subject:Chinese medicine
Abstract/Summary:PDF Full Text Request
Objective:To this topic from clinical comprehensive curative effect, TCM symptoms curative effect, colonoscopy curative effect, histologic efficacy and mucous membrane before and after treatment of activity index changes, the recurrence rate, adverse reactions, etc, this paper discusses the joint ChangMei crushing newsletter kang (Olsalazine) treatment ulcerative colitis (stage) of the clinical curative effect and the ChangMei (Olsalazine) treatment lesions in the same period, whether there is a comparison superiority.Methods:Cases in Hubei province digestive internal medicine clinic hospital selection and the inpatient department in June2010to October2011diagnosis standard according to collect ulcerative colitis (growth) cases58cases were randomly divided into two groups:treatment group (Kui-xun kang+ChangMei group) and the control group (ChangMei group) all29patients. In the determination of the two groups were in baseline data (gender, age, duration, the length of the illness, mucous membrane light severe histological grade, endoscopic grade and mobility etc) through statistical analysis, comparable, were given the control group:oral ChangMei (Olsalazine), acute episode, a total dose3g (12grain), three times of meal used; Maintain a day is1g (4grain),2times a day. The treatment group:Baitouwengl5g GegenlOg Huangqin10g Huanglian6g Ganjiang10g Xuanhu10g Muxiang10g Yiyiren20g Diyutan10g Yunlin15g Baizhu10g Sanqi10g Wumei10g Zhigancao6g in the control group treatment based on to add the crushing newsletter kang:, water frying take a daily agent, twice after eating a hour take, morning and evening each, every time200ml. Both groups to a month for a period of treatment. Observed before and after treatment two sets of patients total curative effect of traditional Chinese medicine clinical symptoms, the therapeutic effect and colonoscopy curative effect and mucous membranes histological change such as curative effect and make detailed records. Will the data collected by SPSS19.0statistical software package, according to the measurement data using t test; Count material using a chi-square test; Grade material using a rank and inspection, the statistical analysis.Results:The treatment group (Kui-xun kang+ChangMei) in clinical curative effect of traditional Chinese medicine, comprehensive sickness curative effect, colonoscopy curative effect, histologic curative effect, mucous membrane activity index changes and the recurrence rate, etc, the statistics processing with significant difference (P<0.05), the treatment group was better than control.Conclusion:This topic research joint ChangMei crushing newsletter kang treatment ulcerative colitis (growth) in clinical comprehensive curative effect, TCM symptoms curative effect, colonoscopy curative effect, histologic efficacy and mucous membrane activity index changes before and after treatment, the recurrence rate, adverse reactions, etc, are better than the control group (ca western medicine group). In traditional Chinese medicine for treating this, specimen, centralizer the principle of evil, in the differentiation, symptomatic treatment the individualized treatment in the treatment of ulcerative colitis aspects reflects its dominant surface. Dyke newsletter kang captures tonify deficiency can remove, specimen and the treatment principles, based on the joint disease differentiation ChangMei (Olsalazine), play with the advantage of combination of Chinese and western, have rapidly improve patients all kinds of clinical symptoms and reduce pain and decrease the recurrence rate, improve the quality of life of the patients and other characteristics, curative effect is accurate. The specific mechanism, function mode is worth deeply research and further expounded.
Keywords/Search Tags:UIcerative colitis, Kui-xun kang, ChangMei (Olsalazine), Clinical observation
PDF Full Text Request
Related items